CA MA · Latest: MA Notice received
Labcorp will acquire BioReference’s laboratory testing businesses focused on clinical diagnostics and reproductive and women’s health across the United States outside of New York and New Jersey.
Provider merger/affiliation increasing NPSR $10M
| State | Agency | Status | Stage | Source |
|---|---|---|---|---|
| CA | Office of Health Care Affordability (HCAI) | CMIR Waived WAIVED | NOTICE | Agency record |
| MA | Massachusetts Health Policy Commission | No NO_CMIR | NOTICE | Agency record |
No changes observed since the initial load (CA · MA ).
Grouped by DocketTrail's reviewed seed list, entry labcorp-bioreference-2024.
| State | Title as printed | Source key | Key method |
|---|---|---|---|
| CA | Laboratory Corporation of America Holdings / and / BioReference Health, LLC | material-change-notice-labcorp-june-2024 | FIRST_DOCUMENT_SLUG |
| MA | BioReference Health, LLC / Laboratory Corporation of America Holdings, Inc. | /sites/default/files/2024-07/20240711_bioreference_-_labcorp_mcn.pdf | FIRST_DOCUMENT_PATH |
| State | Source key | First seen by DocketTrail (UTC) | Last checked (UTC) | Page checked |
|---|---|---|---|---|
| CA | material-change-notice-labcorp-june-2024 | hcai.ca.gov | ||
| MA | /sites/default/files/2024-07/20240711_bioreference_-_labcorp_mcn.pdf | masshpc.gov |
| Source | Last captured (UTC) |
|---|---|
| https://hcai.ca.gov/affordability/ohca/assess-market-consolidation/material-change-transaction-notices-mcn-and-cost-and-market-impact-review-cmir/ | 2026-10-06T20:33:54.638Z |
| https://masshpc.gov/moat/mcn-cmir/mcn-transactions | 2026-10-06T20:34:01.460Z |